Nov 20 2007
Imaging Diagnostic Systems, Inc., a pioneer in laser optical breast cancer imaging systems, announced that the Company will feature breast cancer cases imaged with optical computed tomography technologies at RSNA 2007, in Chicago, Illinois from November 25 - 28. A CT Laser Mammography (CTLM(R)) system and clinical results will be exhibited in the North Building, Hall B, in booth #6600.
The Company will again be included in RSNA's Molecular Imaging Zone, a designation that highlights products, services and research in the emerging field of molecular imaging. CTLM is considered by many to be a cutting-edge modality in this revolutionary field; IMDS is currently conducting a US clinical trial on the use of CTLM as an adjunct to mammography in patients with dense breasts. The clinical trial is part of the Company's effort to seek FDA Premarket Approval (PMA) of the system.
Among the cases that will be presented are several work-in-progress applications including optical fluorescence imaging, assessing the status of presurgical breast cancer chemotherapy treatment compared to MRI, and the potential of using laser optical techniques to aid in categorizing types of ductal carcinoma in situ (DCIS).